The value of multimodal ultrasound in the diagnosis of papillary thyroidcarcinomain hashimoto
返回论文页
|更新时间:2023-10-11
|
The value of multimodal ultrasound in the diagnosis of papillary thyroidcarcinomain hashimoto
Journal of Clinical Ultrasound in MedicineVol. 24, Issue 3, (2022)
作者机构:
1. 西安交通大学第二附属医院医用超声研究室西安
2. 铜川市人民医院铜川
作者简介:
基金信息:
DOI:
CLC:
Published:2022,
Published Online:2 April 2022,
扫 描 看 全 文
The value of multimodal ultrasound in the diagnosis of papillary thyroidcarcinomain hashimoto. [J]. Journal of Clinical Ultrasound in Medicine 24(3).(2022)
DOI:
The value of multimodal ultrasound in the diagnosis of papillary thyroidcarcinomain hashimoto. [J]. Journal of Clinical Ultrasound in Medicine 24(3).(2022)DOI:
The value of multimodal ultrasound in the diagnosis of papillary thyroidcarcinomain hashimoto
Objective: To explore the diagnostic value of thyroid image report and data system (TI-RADS) for papillary carcinoma in the background of Hashimoto''s thyroiditis (HT) by conventional ultrasound classification
ultrasound elastography(UE) and ultrasound contrast(CU) enhanced ultrasound multimodal ultrasound imaging score. Confirmed by pathological methods: select 310 patients with HT merged thyroid nodule
a total of 339 nodules
line of TI - RADS classification
UE and CU
according to the result can be divided into benign nodules and PTC group
on two groups of nodes in a single diagnosis method and the result of combined application of grade distribution comparison
using ROC curve under the background of hashimoto papillary carcinoma diagnosis efficiency analysis and determine the cut-off value. Results: There were statistically significant differences in the single diagnosis method and the combined application of the three methods between the benign nodular group and the PTC group (P < 0.05). Under ROC curve
the AUC and diagnostic efficiency of multimodal ultrasound for papillary carcinoma were significantly higher than that of single diagnosis method (P < 0.05). Conclusion: Multimodal ultrasonography can improve the diagnostic efficiency of PTC in the background of HT. 9.5 The cut-off point values of benign nodules and PTC.